Transcription of NSSG Chemotherapy Protocol - NSSG - Haematology
{{id}} {{{paragraph}}}
Example: quiz answers
NSSG Chemotherapy Protocol - NSSG - Haematology
Lymphoma group This is a controlled document and therefore must not be changed or photocopied R-GemOx Authorised by Lymphoma Lead Dr Graham Collins Published: May 2019 Review: May 2021 Version 1 of 5 43 R-GemOx INDICATION relapsed or refractory Lymphoma, for patients unsuitable for R-GDP regimen. Omit rituximab if CD20- negative TREATMENT INTENT Disease modification PRE-ASSESSMENT 1. Ensure histology is confirmed prior to administration of Chemotherapy and document in notes. 2. Record stage and IPI of disease - CT scan (neck, chest, abdomen and pelvis), and/or PET-CT, presence or absence of B symptoms, clinical extent of disease, consider bone marrow aspirate and trephine.
Relapsed or Refractory Lymphoma, for patients unsuitable for R-GDP regimen. Omit rituximab if CD20- negative TREATMENT INTENT Disease modification PRE-ASSESSMENT 1. Ensure histology is confirmed prior to administration of chemotherapy and document in notes. 2. Record stage and IPI of disease - CT scan (neck, chest, abdomen and pelvis), and/or ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: